Vitamin E in Flax Compared to Tree Nuts and Peanuts

Another notes in progress page: This is pure ChatGPT in response to: convert this a bad copy of info from Google Ai , into succint notes for a post for the flaxlady site: interesting that the type of vitamin E in flax actually works differently and sort of compensate for flax having less even though flax’s antioxidant protection is also supported by lignans:

What it yet again shows is don’t get fooled by some high numbers for nutrient levels; different versions of antioxidant nutrients seldom have the same level of power and whole foods that are apparently lower in a nutrient than another food often are more than supported by other anitoxidants and generally these work synergistically – the whole of the antioxidants together working far more effectively than the sum of the different antioxidants. The big message is we need a good varied diet, with lots of whole foods, complete with their various anioxidants and the body will take advantage of them and use what it needs for health.


🌼 Vitamin E in Flax – Why It’s Special

Flax contains a unique balance of vitamin E compounds (tocopherols) that behave differently in the body.

✨ Not All Vitamin E Works the Same

Vitamin E isn’t a single substance — it’s a family. The two key forms here:

  • Alpha-tocopherol (α-T)
  • Gamma-tocopherol (γ-T) ← dominant form in flax

šŸ”¬ Gamma-Tocopherol (γ-T): Flax’s Standout Form

Although flax contains less total vitamin E than some oils, its γ-tocopherol is biologically powerful:

āœ” Better at neutralising reactive nitrogen species (linked to inflammation)
āœ” Supports anti-inflammatory pathways
āœ” Helps reduce platelet aggregation (circulatory health)
āœ” May help limit LDL oxidation

In short → different mechanism, strong protection – seems to have more protective power in reducing the risk of Alzheimer’sĀ 

 


šŸ›” Antioxidant Support Beyond Vitamin E

Flax’s defence system isn’t reliant on tocopherols alone:

🌿 Lignans (abundant in flax) provide additional antioxidant protection

This means:

Lower vitamin E quantity ≠ lower antioxidant capacity


āš–ļø Alpha vs Gamma Tocopherol – Simple Comparison

Alpha-tocopherol (α-T) Gamma-tocopherol (γ-T)
Main form in tissues Dominant in flax
Strong lipid antioxidant Strong anti-inflammatory activity
Protects cell membranes Neutralises reactive nitrogen species
ā€œClassic vitamin Eā€ ā€œInflammation-focused vitamin Eā€

šŸ’” Why This Matters for Flax

Flax offers:

āœ” A vitamin E form linked with inflammation control
āœ” Synergy with lignans
āœ” Broad antioxidant support

A good reminder that nutrient quality and function matter as much as quantity.


Vitamin E consists of two major different structural forms: α- and γ-tocopherol. In recent in vitro studies, γ-tocopherol has been shown to inhibit lipid peroxidative damage (16)and to trap mutagenic electrophiles (17)more efficiently than α-tocopherol. Further, it is the γ-tocopherol, and not α-tocopherol, that appears to be expressed in low amounts in the plasma of patients with CAD (18). A clinical study has shown that dietary supplementation with α-tocopherol, the primary form of vitamin E in commercial preparations, may further lower plasma γ-tocopherol levels (19).  https://www.sciencedirect.com/science/article/pii/S0002916523064018#:~:text=They%20found%20that%20%CE%B3%2Dtocopherol,of%20%CE%B3%2Dtocopherol%20in%20CVD.

intake from supplements but not from dietary vitamin E. Although the reasons for this discrepancy are not clear, the overall dietary vitamin E (presumably mainly γ-tocopherol) intake in both studies was much lower than the total intake among supplement users. Finally, it was reported that the regular consumption of nuts, which are an excellent source of γ-tocopherol, lowers the risk of myocardial infarction and death from ischemic heart disease (75).
In addition to the above-cited human studies, several animal studies also provide some evidence that γ-tocopherol might be beneficial against CVD. Saldeen et al (76) investigated the effects of α- and γ-tocopherol supplementation on platelet aggregation and thrombosis in Sprague Dawley rats. They found that γ-tocopherol supplementation led to a more potent decrease in platelet aggregation and delay of arterial thrombogenesis than did α-tocopherol supplementation (76). γ-Tocopherol supplementation also resulted in stronger ex vivo inhibition of superoxide generation, lipid peroxidation, and LDL oxidation. In a follow-up study, this same group reported that γ-tocopherol was significantly more potent than was α-tocopherol in enhancing SOD activity in plasma and arterial tissue and in increasing the arterial protein expression of both manganese SOD and Cu/Zn SOD (77). Furthermore, although both tocopherols increased nitric oxide generation and endothelial nitric oxide synthase activity, only γ-tocopherol supplementation resulted in increased protein expression of this enzyme (77). Because endothelium-derived nitric oxide is a key regulator of vascular homeostasis, up-regulation of endothelial nitric oxide synthase and nitric oxide formation by γ-tocopherol could be important in preventing vascular endothelial dysfunction (78). Together, the abovementioned human and animal studies seem to warrant further investigations into the role of γ-tocopherol in CVD.
https://www.sciencedirect.com/science/article/pii/S0002916523064018#:~:text=They%20found%20that%20%CE%B3%2Dtocopherol,of%20%CE%B3%2Dtocopherol%20in%20CVD.